Published in Pharma Law Weekly, July 14th, 2009
"The preventive group was treated for 10 weeks with anisodamine 7.0 mg/kg per day i.p. injection. Two therapeutic groups were treated for 6 weeks by anisodamine 7.0 or 14.0 mg/kg per day i.p. injection. Studies were made at CCL4 administration on the 10th weekend. Serum biochemical indices and the contents of malondialdehyde (MDA) and hydroxyproline (HYP) in livers were compared. The expression of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Law Weekly